PG vs RIGL · P/E 25, rev $84.28B vs P/E 9.1, rev $179.3M
Procter & Gamble Company (PG) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the PG and RIGL stock pages for the full models.
Not investment advice.